Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHipgnosis Song. Regulatory News (SONG)

Share Price Information for Hipgnosis Song. (SONG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.60
Bid: 104.60
Ask: 104.80
Change: -0.20 (-0.19%)
Spread: 0.20 (0.191%)
Open: 104.60
High: 105.20
Low: 104.40
Prev. Close: 104.80
SONG Live PriceLast checked at -
Hipgnosis Songs is an Investment Trust

To provide shareholders with an attractive and growing level of income, together with the potential for capital growth, from investment in songs and associated musical intellectual property rights.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on dividend intentions

6 Nov 2023 07:00

RNS Number : 4168S
Hipgnosis Songs Fund Limited
06 November 2023
 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

LEI: 213800XJIPNDVKXMOC11

 

 

Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")

 

Update on Dividend Intentions

6 November 2023 

 

The Board of Hipgnosis Songs Fund Limited together with its Investment Adviser, Hipgnosis Song Management Limited, have been undertaking a review of the Company's financial position as a result of which the Board has determined that it will not declare dividends before the new financial year.

As a result of this review:

· It has been determined that the Catalogue bonus provision is expected to increase by approximately $23 million to $68 million at 30 September 2023 as there are now ten (31 March 2023: six) out of the Company's 146 Catalogues likely to meet performance hurdles as defined in their acquisition agreements. The $68 million would be payable over a period of three years from 30 September 2023, with $40 million due within 12 months, $24 million due within 1-2 years and $4 million due within 2-3 years. In addition, there are a further nineteen Catalogues with active bonus provisions totalling $75 million, that are unlikely to meet performance hurdles; these are not recognised as provisions but are contingent liabilities and will be disclosed in the forthcoming interim results with associated sensitivity analysis.

 

· The Board, advised by the Investment Adviser, is exploring refinements to the methodology adopted in the Company's revenue accrual estimation process for the year end results which, based on early assessments, may result in an accrual adjustment reducing revenue accruals by up to 10%. Any changes would aim to bring consistency to the description of IFRS revenue and the Pro Forma Annual Revenue measure through the use of granular data in the underlying calculations, to support an improved estimation process and enhanced disclosures.

 

 

In light of this information, the Board has determined that it will not declare dividends before the new financial year. The operating cash flow of the Company during this time will therefore be used to ensure that the Company has sufficient cash resources to fund the payment of the Catalogue bonuses as required. Additionally, the suspension of dividend payments will provide the Company with the headroom required to maintain compliance with its revolving credit facility's Fixed Charge Cover Ratio covenant if the accrual adjustment is realised in full.

The Board will update the Company's dividend policy as part of proposals which are due to be made to shareholders by 26 April 2024 following completion of the Strategic Review.

The person responsible for making this notification is Sylvia Coleman, Senior Independent Director of Hipgnosis Songs Fund Limited.

 

 

For further information please contact:

 

Hipgnosis Songs Fund Limited

Sylvia Coleman

via Singer Capital Markets

+44 (0) 20 7496 3000

Hipgnosis Song Management

Merck Mercuriadis

Ben Katovsky

Giles Croot (Media)

+44 (0) 20 4542 1530

+44 (0) 20 4542 1511

Headland Consultancy - Financial PR

Susanna Voyle / Charlie Twigg

 

+44 (0) 20 3805 4822

J.P. Morgan Cazenove - Sponsor, Financial Adviser and Corporate Broker

William Simmonds / Jérémie Birnbaum (Corporate Finance)

+44 (0) 20 3493 8000

Singer Capital Markets - Corporate Broker

James Moat / Angus Campbell (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales) 

+44 (0) 20 7496 3000

RBC Capital Markets - Corporate Broker

Elliot Thomas / Max Avison (Corporate Finance)

 

+44 (0) 20 7635 4000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAAFSEDADFAA
Date   Source Headline
2nd Jul 20207:00 amRNSPlacing of C Shares & Date of Full Year Results
25th Jun 20206:17 pmRNSPublication of Supplmentary Prospectus
22nd Jun 20205:16 pmRNSHolding(s) in Company
12th Jun 202012:30 pmRNSDirector/PDMR Shareholding
12th Jun 20207:00 amRNSContemplation of Equity Raise & Result of EGM
4th Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSUnaudited NAV and Trading Update
29th May 20203:03 pmRNSProposed Amendment to Borrowing Policy
14th May 20207:01 amRNSDirector/PDMR Shareholding
14th May 20207:00 amRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSDirector/PDMR Shareholding
29th Apr 20207:00 amRNSInterim Dividend Declaration
23rd Apr 20207:00 amRNSAcquisition of Music Catalogue
15th Apr 20207:00 amRNSIncreased Debt Facility
1st Apr 20204:00 pmRNSChange of Name of Administrator/Company Secretary
30th Mar 20207:00 amRNSAcquisition of Music Catalogue
25th Mar 202012:03 pmRNSPrice Monitoring Extension
23rd Mar 20205:03 pmRNSDirector/PDMR Shareholding
19th Mar 20201:56 pmRNSDirector/PDMR Shareholding
18th Mar 20202:18 pmRNSDirector/PDMR Shareholding
17th Mar 202011:36 amRNSInvestment Adviser Purchase of Shares
16th Mar 20204:04 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFTSE 250 Index Inclusion
2nd Mar 20207:00 amRNSTotal Voting Rights
26th Feb 20207:00 amRNSContemplation of Equity Raise and USD Quote
14th Feb 202011:52 amRNSDirectors' Share Holdings
7th Feb 20205:30 pmRNSHipgnosis Songs Fund
7th Feb 20207:00 amRNSNAV's, C Share Conversion and Total Voting Rights
3rd Feb 20207:00 amRNSTotal Voting Rights
24th Jan 20207:00 amRNSAcquisition of Music Catalogue
23rd Jan 20207:00 amRNSDividend Declaration
17th Jan 20207:00 amRNSAcquisition of Music Catalogue
13th Jan 20207:00 amRNSConversion of C Shares
9th Jan 20207:00 amRNSAcquisition of Music Catalogue
7th Jan 20207:00 amRNSAcquisition of Music Catalogue
30th Dec 20197:00 amRNSPerformance Fee and Total Voting Rights
20th Dec 20197:00 amRNSAcquisition of Music Catalogue
18th Dec 20197:00 amRNSAcquisition of Music Catalogue
17th Dec 20197:00 amRNSAcquisition of Music Catalogue
16th Dec 20193:11 pmRNSDirector/PDMR Shareholding
12th Dec 20197:00 amRNSAcquisition of Music Catalogue
11th Dec 20197:01 amRNSAcquisition of Music Catalogue
11th Dec 20197:00 amRNSInterim Results
10th Dec 20197:00 amRNSAcquisition of Music Catalogue
9th Dec 20194:47 pmRNSInvestor Call on 12 December 2019
3rd Dec 20197:00 amRNSAcquisition of Music Catalogue
27th Nov 20197:00 amRNSAppointment of Non-Executive Director
25th Nov 20197:00 amRNSNet Asset Value and Notice of Results
19th Nov 20199:00 amRNSLSE Welcomes Hipgnosis to Premium Segment
1st Nov 20197:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.